In early 2020, we published some initial research on how cannabis, specifically cannabidiol, can help us heal from zoonotic diseases. It’s a very logical and unsurprising stance considering the healing benefits of the plant and how in synch we are with cannabis due to how many cannabinoid receptors we have externally and internal, on and within the human body.
Two years later, not only have we noticed a great correlation between lack of infections and people who consume the plant, but new research out of Oregon State’s Global Hemp Innovation Center, College of Pharmacy, and Linus Pauling Institute found that two compounds commonly found in hemp have the potential to combat the coronavirus. The compounds cannabigerolic acid, or CBGA, and cannabidiolic acid, CBDA, block a critical step in the process the virus uses to infect people.
CBDa is the parent compound to CBD and is made with living hemp, which helps sustain the plant’s natural molecular structure. CBDa is much higher quality than CBD and people who consume it reap the benefits of the plant’s healthy fats, vitamins, and beneficial phytonutrients – resulting in restored cellular balance, restfulness, and rejuvenation.
The researchers tested the compounds’ effect against alpha and beta variants of the virus in a laboratory. The study didn’t involve giving the supplements to people or comparing infection rates in those who use the compounds to those who don’t.
“These compounds can be taken orally and have a long history of safe use in humans,” said Richard van Breemen, a researcher with Oregon State’s Global Hemp Innovation Center. “They have the potential to prevent as well as treat infection by SARS-CoV-2,” he said in a statement.